Login
Toggle navigation
Videos
Categories
Trending
Philip Toleikis, Ph.D., CEO and President, Sernova Corp
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Philip Toleikis, Ph.D., CEO and President, Sernova Corp
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Interview with Brian O'Neal: From Air Force Pilot to Financial Advisor | Brian O'Neil, CEO, Winged Wealth Management and Financial Planning LLC
00:00:00
Dedicare - ABGSC Investor Days 8 mars 2022 - Krister Widstrom, CEO, Dedicare AB (publ)
00:10:00
CEO Ton Hillen's Electric Ride: Insights on Sustainability and Challenges | Mr. A.G.J. (Ton) Hillen - CEO of Heijmans
00:10:00
Honoring Our Heroes: CIRCOR International's Commitment to Military Veterans
00:10:00
Truepoint's Innovative Office Design Enhances Client Experience and Team Collaboration
00:10:00
BCI Minerals Targets High-Grade Iron Ore and Salt Production in Western Australia
00:10:00
Assessing Intelligence Failures: The Case of WMDs in Iraq|James Woolsey
00:10:00
Recent Drilling Results at AMEX Exploration's Perron Project
00:10:00
A10 Networks and Dell Technologies Deliver Hybrid Cloud Application Reliability and User Protection | Dhrupad Trivedi, CEO, A10 Networks IncATEN:NYQ
00:10:00
Transforming Agriculture in Africa: The Technologies for African Agricultural Transformation Initiative (TAT)
00:10:00
Embrace of digital commerce has become a cornerstone of its economic landscape|Cindy Bi,General Partner, CapitalX
00:10:00
working on mission-driven startups with a sustainable social impact|Kasem Rodriguez Mohsen,Founding Partner,Equilibrium Impact Ventures